Answers are grounded in this paper and cite their sources.
The purpose of our study was to determine the effectiveness of thetherapymassiveobstetric bleeding (MOH), which arose under various etiological factors, with the introduction of the modern concept of resuscitation of damage control (DCR – Damage Control Resuscitation) and innovative methods of surgical hemostasis. Materials and research methods. During 2015 – 2023 years at clinical bases of the Department of Ob/Gyn. No1 of PL Shupyk NHU of Ukraine, 165 cases of MOH were analyzed. In all MOH cases, an integrated approach was used to stop bleeding using both drug therapy and modern methods of surgical hemostasis in accordance with the regulatory documents of the Ukrainian Ministry of Health. The main group – 59 women in labor with the MOH (2020-2023), who used in integrated approach to stopping bleeding and restoring blood loss according to the Concept of DCR with the priority of high-quality and rapid restoration of blood loss with blood products with minimization of infusion therapy. The comparison group consisted of 106 women in labor with MOH (2015-2019) and similar methods of stopping bleeding to restore blood loss in accordance with the order No. 205 of the Ukrainian Ministry of Health with the priority of rapid recovery of blood loss by crystalloids (during 2015-2019). Research results. The mean blood loss, time to stop bleeding, and duration of surgery in the intervention group were significantly lower than in the comparison group (p < 0.05). In the postpartum period, cases of severe anemia were significantly more often observed in the comparison group – 47.2% versus 11.9% in the main group (p < 0.01). The number of cases of hysterectomies was significantly higher in the comparison group – 50.9% versus 28.8% (p < 0.01). Early onset and significantly higher rate of fresh frozen plasma transfusions and erythromas in the main gr. – respectively 88.1% versus 38.7% (p < 0.001), which affected significantly lower blood loss, duration of surgery and average time to stop bleeding in the main group to the comparison group (p < 0.05). Conclusions. The use of modern uterotonic agents (carbetocin), tranexamic acid, innovative surgical technologies and early initiation of transfusion therapy with blood products with minimization of crystalloid infusion and according to the DCR concept in the MOH allows to reduce blood loss, frequency of severe postpartum complications, prevent severe maternal morbidity and mortality.
No takes yet. Share an insight, caveat, or question.
Golyanovskiy et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: